Showing results (1591-1600 of 2,791) with videos related to

Sort By:
Pageof 280
Cytotherapy|June 19, 2004
DCs as targets for vaccine designGt Belz, Cm Smith, M Bharadwaj, et al.
Cytotherapy|June 19, 2004
DC therapy for prostate cancerP W Swindle, S Tepes, J Clements
Cytotherapy|October 10, 2022
Towards sustainability and affordability of expensive cell and gene therapies? Applying a cost-based pricing model to estimate prices for Libmeldy and ZolgensmaFrederick W Thielen, Renaud J S D Heine, Sibren van den Berg, et al.
Cytotherapy|September 1, 2022
Concurrent transposon engineering and CRISPR/Cas9 genome editing of primary CLL-1 chimeric antigen receptor-natural killer cellsMark Gurney, Eimear O'Reilly, Sarah Corcoran, et al.
Cytotherapy|October 18, 2022
Evaluation of human adipose-derived mesenchymal stromal cell Toll-like receptor priming and effects on interaction with prostate cancer cellsCosette M Rivera-Cruz, Marxa L Figueiredo
Cytotherapy|September 19, 2019
Mesenchymal stem versus stromal cells: International Society for Cell & Gene Therapy (ISCT®) Mesenchymal Stromal Cell committee position statement on nomenclatureS Viswanathan, Y Shi, J Galipeau, et al.
Cytotherapy|March 16, 2019
Recent progress on developing exogenous monocyte/macrophage-based therapies for inflammatory and degenerative diseasesMable Wing Yan Chan, Sowmya Viswanathan
Cytotherapy|May 14, 2014
Human cord blood stem cell paracrine factors activate the survival protein kinase Akt and inhibit death protein kinases JNK and p38 in injured cardiomyocytesRobert J Henning, Paul Sanberg, Ernesto Jimenez
Cytotherapy|October 27, 2018
Empowering dendritic cell cancer vaccination: the role of combinatorial strategiesDomenico Galati, Serena Zanotta
Cytotherapy|February 1, 2014
Third-party umbilical cord blood-derived regulatory T cells prevent xenogenic graft-versus-host diseaseSimrit Parmar, Xiaoying Liu, Shawndeep S Tung, et al.
Pageof 280